$WDDD
Worlds Inc Stock $wddd

$wddd Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000126493122000157 Filed on August 10, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue			$0.00
YoY Change
Cost Of Revenue			$0.00
YoY Change
Gross Profit			$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$47.30K	$140.9K	$123.3K
YoY Change	-77.3%	-75.11%	-65.03%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$47.30K	$140.9K	$123.3K
YoY Change	-77.3%	-75.11%	-65.03%
Operating Profit	-$100.4K	-$208.6K	-$123.3K
YoY Change	-51.8%	-68.8%	-65.03%
Interest Expense	$19.13K	$18.92K	-$15.55K
YoY Change	-84.83%	0.0%	-34.03%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$20.58K	$14.82K	-$138.9K
YoY Change	-125.02%	-77.14%	-63.09%
Income Tax
% Of Pretax Income
Net Earnings	$20.58K	$14.82K	-$138.9K
YoY Change	-125.02%	-77.13%	-63.09%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$360.30	$259.50	-$2.432K
COMMON SHARES
Basic Shares Outstanding	57.11M shares	57.11M shares
Diluted Shares Outstanding	57.11M shares	57.11M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.00K	$36.97K	$44.42K
YoY Change	-83.05%	-94.29%	-90.64%
Cash & Equivalents	$58.00K	$36.97K	$44.42K
Short-Term Investments
Other Short-Term Assets	$8.222K	$8.222K	$8.222K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$66.22K	$45.20K	$52.64K
YoY Change	-80.65%	-94.81%	-88.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$242.1K	$238.5K	$231.5K
YoY Change	6.23%		6.54%
TOTAL ASSETS
Total Short-Term Assets	$66.22K	$45.20K	$52.64K
Total Long-Term Assets	$242.1K	$238.5K	$231.5K
Total Assets	$308.3K	$283.7K	$284.1K
YoY Change	-45.92%	-67.44%	-58.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$807.1K	$827.9K	$975.3K
YoY Change	-28.82%	-2.31%	-0.68%
Accrued Expenses	$1.564M	$1.559M	$1.546M
YoY Change	0.67%	-24.98%	-3.74%
Deferred Revenue
YoY Change
Short-Term Debt	$773.3K	$773.3K	$773.3K
YoY Change	0.0%	0.0%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.145M	$3.161M	$3.295M
YoY Change	-9.14%	-14.57%	-1.98%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.145M	$3.161M	$3.295M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.145M	$3.161M	$3.295M
YoY Change	-9.14%	-14.57%	-1.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.49M	-$46.51M	-$45.79M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.837M	-$2.877M	-$3.011M
YoY Change
Total Liabilities & Shareholders Equity	$308.3K	$283.7K	$284.1K
YoY Change	-45.92%	-67.44%	-58.94%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	$20.58K	$14.82K	-$138.9K
YoY Change	-125.02%	-77.13%	-63.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$112.0K	-$262.5K	-$294.2K
YoY Change	-74.73%	-28.26%	-5.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$992.4K
YoY Change			-7073.93%
Cash From Investing Activities			$992.4K
YoY Change			-7073.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	133.0K	599.1K
YoY Change	-3.69%	39.26%
NET CHANGE
Cash From Operating Activities	-112.0K	-262.5K	-294.2K
Cash From Investing Activities			992.4K
Cash From Financing Activities	133.0K	599.1K
Net Change In Cash	21.03K	336.6K	698.2K
YoY Change	-106.9%	423.2%	-321.07%
FREE CASH FLOW
Cash From Operating Activities	-$112.0K	-$262.5K	-$294.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000001961
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
	WDDD	Loss On Issuance Of Shares For Services LossOnIssuanceOfSharesForServices		usd
CY2022Q2	WDDD	Loss On Issuance Of Shares For Services LossOnIssuanceOfSharesForServices		usd
CY2021Q2	WDDD	Loss On Issuance Of Shares For Services LossOnIssuanceOfSharesForServices		usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-24115
	dei	Entity Registrant Name EntityRegistrantName	WORLDS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-1848316
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11 Royal Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Brookline
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02445
	dei	City Area Code CityAreaCode	(617)
	dei	Local Phone Number LocalPhoneNumber	725-8900
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57112506	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36973	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44421	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	8222	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8222	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	45195	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	52643	usd
CY2022Q2	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	200000	usd
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	200000	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	38500	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	31461	usd
CY2022Q2	us-gaap	Assets Assets	283695	usd
CY2021Q4	us-gaap	Assets Assets	284104	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	827910	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	975255	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1559420	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1546480	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	773279	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	773279	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3160609	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3295014	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3160609	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3295014	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57112506	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57112506	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57112506	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57112506	shares
CY2022Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	57113	usd
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	57113	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42372656	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	41513730	usd
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1206913	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1206913	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46513596	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45788666	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2876914	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3010910	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	283695	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	284104	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	821296	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	109874	usd
CY2022Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	15904	usd
CY2021Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	51692	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	377530	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1319571	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	140905	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	566137	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	101649	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	104065	usd
CY2022Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	51755	usd
CY2021Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	50709	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3010910	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	821296	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1300475	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1533510	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-208563	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-668538	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	37630	usd
	us-gaap	Net Income Loss NetIncomeLoss	-724930	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2876914	usd
	us-gaap	Net Income Loss NetIncomeLoss	-724930	usd
	us-gaap	Net Income Loss NetIncomeLoss	-393040	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	821296	usd
	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	606136	usd
	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	864926	usd
CY2022Q2	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	238767	usd
CY2021Q2	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	433735	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	315000	usd
CY2021Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	315000	usd
	WDDD	Loss On Issuance Of Shares For Services LossOnIssuanceOfSharesForServices	-8685	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	7039	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	7039	usd
CY2022Q2	us-gaap	Interest Income Operating InterestIncomeOperating	3539	usd
CY2021Q2	us-gaap	Interest Income Operating InterestIncomeOperating	3539	usd
	us-gaap	Interest Expense InterestExpense	37630	usd
	us-gaap	Interest Expense InterestExpense	37810	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	18919	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	18919	usd
	us-gaap	Net Income Loss NetIncomeLoss	-724930	usd
	us-gaap	Net Income Loss NetIncomeLoss	-393040	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	14823	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	64817	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57112506	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57031920	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57112506	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57112506	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2669888	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	109874	usd
	WDDD	Common Stock Issued For Settlement Of Accounts Payable Related Party1 CommonStockIssuedForSettlementOfAccountsPayableRelatedParty1	70810	usd
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	16401	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	37810	usd
	us-gaap	Net Income Loss NetIncomeLoss	-393040	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-2828033	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	109874	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	8685	usd
	us-gaap	Increase Decrease In Marketable Securities Restricted IncreaseDecreaseInMarketableSecuritiesRestricted	-606136	usd
	us-gaap	Increase Decrease In Marketable Securities Restricted IncreaseDecreaseInMarketableSecuritiesRestricted	-864926	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	37630	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	37810	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-134405	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	416237	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-606544	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-685359	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	606136	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	864926	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7039	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7039	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	599097	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	857887	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7448	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	172528	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44421	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	474587	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36973	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	647115	usd
	us-gaap	Stock Issued1 StockIssued1	62125	usd
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	16401	usd
	WDDD	Working Capital Deficiency WorkingCapitalDeficiency	2876914	usd
	WDDD	Stockholders Deficiency StockholdersDeficiency	2876914	usd
	WDDD	Cash In Operations Deficiency CashInOperationsDeficiency	606544	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	142	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zwzrSNXfnkob" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. </p> <p style="font: 4pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p id="xdx_84E_eus-gaap--RevenueRecognitionAllowances_zR0ic4Znwi82" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 1, 2018, the Company adopted ASC 606. There was no impact in adopting ASC 606 as the Company has no revenue at this time. In the second quarter of 2011, the Company spun off its online businesses to MariMed Inc. The Company’s sources of revenue after the spinoff was expected to be from sublicenses of the patented technology by Worlds Online and any revenue that may be generated from enforcing its patents. Commencing in the first half of 2022, the Company expects that its revenues will come from its expansion of its legacy celebrity worlds and its collection of non-fungible tokens. The Company recognizes revenue by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	50%
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	773279	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	773279	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27620000	shares
CY2021Q2	WDDD	Warrant Or Right Outstanding WarrantOrRightOutstanding	4380000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11720000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4380000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.05
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	0.05
CY2022Q2	WDDD	Options Expected Life OptionsExpectedLife	5
CY2022Q2	WDDD	Options Vest Period OptionsVestPeriod	6	interger
CY2022Q1	WDDD	Options Repriced OptionsRepriced	900000	shares
	WDDD	Option Expense1 OptionExpense1	38444	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	297673	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	70810	usd
	WDDD	Loss On Shares Issued LossOnSharesIssued	8685	usd
CY2001Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	205000	usd
CY2022Q2	us-gaap	Litigation Reserve LitigationReserve	205000	usd
CY2021Q4	us-gaap	Litigation Reserve LitigationReserve	205000	usd
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p id="xdx_849_eus-gaap--DerivativesEmbeddedDerivatives_zg3SzM8lWRhl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Embedded Conversion Features </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	109874	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	821296	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_849_eus-gaap--DerivativesReportingOfDerivativeActivity_zLPjhiDR1hbf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Financial Instruments</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. </p> <p style="font: 4pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt/106% Times New Roman, Times, Serif; margin: 0 0 8pt"><b> </b></p>
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	124230000	usd
CY2022Q2	WDDD	Convertible Notes Payable1 ConvertibleNotesPayable1	649049000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	773279	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	773279	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	-0	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	-0	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	-0	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	-0	usd
CY2022Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	18919	usd
CY2018Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	5	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod	15900000	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	300000	shares
	WDDD	Option Expense OptionExpense	31108	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	1.37	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2018Q3	WDDD	Terms Of Employment Agreement TermsOfEmploymentAgreement	5
CY2018Q3	WDDD	Terms Of Employment Agreement Renewal Option TermsOfEmploymentAgreementRenewalOption	1
CY2018Q3	WDDD	Officer Base Salary OfficerBaseSalary	200000	usd
CY2018Q3	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.10	pure
CY2018Q3	WDDD	Car Allowance CarAllowance	500	usd
CY2018Q3	WDDD	Annua Bonus AnnuaBonus	0.025	pure
CY2018Q3	WDDD	Additional Bonus AdditionalBonus	75000	usd
CY2018Q3	WDDD	Pretax Income Range Lower PretaxIncomeRangeLower	1.50
CY2018Q3	WDDD	Pretax Income Range Higher PretaxIncomeRangeHigher	200
CY2018Q3	WDDD	Additional Bonus Exceed AdditionalBonusExceed	0.05	pure
CY2018Q3	us-gaap	Life Settlement Contracts Investment Method Five Year Disclosure Premiums To Be Paid LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid	10000	usd
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	5000000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.25
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2000000	shares
CY2019Q3	WDDD	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1	1500000	shares
CY2020Q3	WDDD	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1	1500000	shares
CY2018Q3	us-gaap	Life Settlement Contracts Fair Value Method Face Value LifeSettlementContractsFairValueMethodFaceValue	2000000	usd
CY2018Q3	WDDD	Payment Amount Based PaymentAmountBased	2.99	pure
CY2018Q3	WDDD	Restrictive Convenants Amount RestrictiveConvenantsAmount	12	interger
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	297673	shares
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	70810	usd
	WDDD	Loss On Shares Issued LossOnSharesIssued	8685	usd
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	16401	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	46438	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	33899	usd
	us-gaap	Revenue Recognition Services Licensing Fees RevenueRecognitionServicesLicensingFees	<p id="xdx_80F_eus-gaap--RevenueRecognitionServicesLicensingFees_z4f5enIuujEj" style="font: 11pt/15.95pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>NOTE 7 - <span id="xdx_822_zbBN3W0GEK83">PATENTS</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Worlds Inc. currently has <span id="xdx_90E_ecustom--NumberOfPatents_dc_uInterger_c20220101__20220630_zlOh3r1NOfOj" title="Patents">nine </span>patents, <span id="xdx_90F_ecustom--PatentNumberOne_uInterger_c20220101__20220630_z1JgLstSJjP6" title="Patent number one">6,219,045</span> - <span id="xdx_900_ecustom--PatentNumberTwo_uInterger_c20220101__20220630_z6Qz5FneHdl2" title="Patent number two">7,181,690 </span>- <span id="xdx_902_ecustom--PatentNumberThree_uInterger_c20220101__20220630_zLf4lVg03uHg" title="Patent number three">7,493,558</span> – <span id="xdx_906_ecustom--PatentNumberFour_uInterger_c20220101__20220630_zLHVebWGmBV7" title="Patent number four">7,945,856</span>, - <span id="xdx_903_ecustom--PatentNumberFive_uInterger_c20220101__20220630_zPwe5HENefq7" title="Patent number five">8,082,501</span>, – <span id="xdx_90F_ecustom--PatentNumberSix_uInterger_c20220101__20220630_z2gyYeA9BzVb" title="Patent number six">8,145,998</span><span id="xdx_904_ecustom--PatentNumberSeven_uInterger_c20220101__20220630_ze1dhSrJZPM6" title="Patent number seven">8,161,383</span>, – <span id="xdx_90A_ecustom--PatentNumberEight_uInterger_c20220101__20220630_zgsZWe42sAk3" title="Patent number eight">8,407,592</span> and <span id="xdx_90E_ecustom--PatentNumberNine_uInterger_c20220101__20220630_zC3wao52vZRl" title="Patent number nine">8,640,028</span>.</p> <p style="font: 4pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt/106% Times New Roman, Times, Serif; margin: 0 0 8pt"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	WDDD	Number Of Patents NumberOfPatents	9	interger
	WDDD	Patent Number One PatentNumberOne	6219045	interger
	WDDD	Patent Number Two PatentNumberTwo	7181690	interger
	WDDD	Patent Number Three PatentNumberThree	7493558	interger
	WDDD	Patent Number Four PatentNumberFour	7945856	interger
	WDDD	Patent Number Five PatentNumberFive	8082501	interger
	WDDD	Patent Number Six PatentNumberSix	8145998	interger
	WDDD	Patent Number Seven PatentNumberSeven	8161383	interger
	WDDD	Patent Number Eight PatentNumberEight	8407592	interger
	WDDD	Patent Number Nine PatentNumberNine	8640028	interger
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	46438	usd
CY2001Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	205000	usd
CY2022Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1305009	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2972	usd
CY2022Q2	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	200000	usd
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	7	pure
	WDDD	Maturity Terms MaturityTerms	2
CY2022Q2	WDDD	Warrants Warrants	1000000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.05
CY2022Q2	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	38500	usd
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	29303395	shares
	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	0.008139
CY2022Q2	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.01	pure
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	7039	usd
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	7039	usd
CY2011Q1	WDDD	Retained Shares RetainedShares	5936115	shares
	WDDD	Retained Shares Own Value RetainedSharesOwnValue	0	usd
	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	606136	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	900000	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.70
	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	864926	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1095000	shares
CY2020Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100000	shares
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.79
CY2022Q2	WDDD	Retained Shares Own RetainedSharesOwn	850000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit		usd

Files In Submission

Name	View Source	Status
0001264931-22-000157-index-headers.html	Edgar Link	pending
0001264931-22-000157-index.html	Edgar Link	pending
0001264931-22-000157.txt	Edgar Link	pending
0001264931-22-000157-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wddd-20220630.xsd	Edgar Link	pending
wddd10q222.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
wddd-20220630_lab.xml	Edgar Link	unprocessable
wddd-20220630_def.xml	Edgar Link	unprocessable
wddd-20220630_pre.xml	Edgar Link	unprocessable
wddd10q222_htm.xml	Edgar Link	completed
wddd-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WDDD
Worlds Inc Stock $wddd

2022 Q3 Form 10-Q Financial Statement

#000126493122000157 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WDDD Worlds Inc Stock $wddd

2022 Q3 Form 10-Q Financial Statement

#000126493122000157 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WDDD
Worlds Inc Stock $wddd